Form 4 for DGX Quest Diagnostics
Accepted 2025-08-21 00:00:00 ET · period of report 2025-08-19 · accession 0001022079-25-000198 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-21 | 2025-08-19 | DGX | Plewman Patrick | SVP for Diagnostic Services | M - OptEx | $112.17 | +4,532 | 21.8K | +26% | +$508.4K |
| D | 2025-08-21 | 2025-08-19 | DGX | Plewman Patrick | SVP for Diagnostic Services | S - Sale+OE | $183.00 | -4,532 | 17.2K | -21% | -$829.4K |
| D | 2025-08-21 | 2025-08-19 | DGX | Plewman Patrick | SVP for Diagnostic Services | M - OptEx | $112.17 | -4,532 | 0 | -100% | -$508.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-19 | M | A | 4,532 | $112.17 | 21,776 | D | — | — | |
| 2 | Common | Common Stock | 2025-08-19 | S | D | 4,532 | $183.00 | 17,244 | D | — | — | |
| 3 | Derivative | Non-Qualifed Stock Option (right to buy) | 2025-08-19 | M | D | 4,532 | $112.17 | 0 | D | $112.17 · — to 2030-02-18 | 4,532 Common Stock | (F2) The options vested in three annual installments beginning with the first on February 18, 2021, the second on February 18, 2022 and the final on February 18, 2023. |